“Asian ginseng (Panax ginseng) has stimulant effects on the central nervous system.”

NCCIH states that people take Asian ginseng for “**increasing well‑being, increasing stamina, and improving mental and physical performance**,” but emphasizes that “**studies of Asian ginseng in people have had conflicting results.**” It lists side effects such as **trouble sleeping and headache** and notes possible interactions with medications, indicating that while CNS effects are reported, consistent stimulant‑like benefits have not been firmly established.

“Ginseng and ginsenosides affect various aspects of neurodevelopmental disorder including AD and PD as well as neuropsychiatric disorders and even ischemic stroke… In addition, the memory improving effects of Rb1 or M1 were maintained even after the discontinuation of Rb1 and M1 administration suggesting they induced a long lasting and probably structural reorganization of the damaged brain circuits… In healthy volunteers, acute or chronic treatment of ginseng extracts produced both positive and negative results in cognitive functional tests… preventing a generalized conclusion on the psychoactive properties of ginseng.”

“These studies covered the efficacy of ginseng in areas such as cardiovascular function, glucose metabolism, sexual function, anti-oxidation, anti-fatigue and psychomotor function… The main adverse events of ginseng reported were general symptoms such as hot flushes, insomnia and dyspepsia with no significant difference in frequency and symptoms between the ginseng and placebo groups… Panax ginseng showed a very safe profile… However, to increase the usefulness and lower the health risk… clinical trials on a larger scale and with a higher standard are necessary to define its efficacy and safety as a dietary supplement or complementary medicine.”

“Panax ginseng C.A. Mey has direct effects on the central nervous system (CNS), including cognition, sleep disorders, depression, pain, and the ability to regulate inflammatory cytokines… The present findings supported, to a certain degree, that PGC can be recommended for routine use in fatigue… The possible mechanism of PGC resists fatigue, mainly through antioxidant stress, regulating carbohydrate metabolism, delaying the accumulation of metabolites, promoting mitochondrial function, neuroprotection, antiapoptosis, and regulating neurotransmitter disorder in central nervous system.”

“The signature bioactive ingredients of ginseng are ginsenosides, which are triterpene saponins. However, the therapeutic effects of ginseng are not solely dependent on ginsenosides. Recently, the active ingredient gintonin was identified.” “They show various anti‑inflammatory, antioxidant, antibacterial, antiviral, and antifungal activities. Moreover, they have been demonstrated to have therapeutic potential in hypertension, stress, and different neurological disorders such as Alzheimer's disease (AD), Parkinson disease (PD), and Huntington disease.” “Different studies have revealed that the components of Panax ginseng, especially the ginsenosides Rb1, Rb2, Rb3, Rc, Rd, Re, Rg1, Rg2, and Rg3, have significant therapeutic effects in various neurological disorders, such as memory, anxiety, depression, epilepsy, stroke, amyotrophic lateral sclerosis, AD, PD, and Huntington disease.”

In a section on pharmacology, this review notes that Panax ginseng "has been reported to exert effects on the central nervous system, including psychostimulant and adaptogenic activities" and that ginsenosides "affect neurotransmission and neuroendocrine function." These CNS-related effects are part of the rationale for its traditional use to combat fatigue and improve mental performance.

In this randomized, double-blind, placebo-controlled trial in 90 subjects with idiopathic chronic fatigue, the authors report that Panax ginseng "significantly improved" mental fatigue scores compared with placebo for certain measures. They conclude: "Taken together, these data lead us to conclude that P. ginseng can be used to combat chronic fatigue and that the mechanism underlying this effect may be related to its antioxidant properties." The study demonstrates central (mental) fatigue–related benefits but does not characterize the herb as a classical central nervous system stimulant.

In the section on molecular mechanisms and neurotransmission, the authors note that “Ginsenosides increased levels of dopamine and norepinephrine in the cerebral cortex (Itoh et al., 1989)….” and state that “**Ginsenosides have a general stimulatory effect on the brain** (Radad et al., 2011).” These are described as effects on glutamatergic neurotransmission and other CNS pathways.

This review summarizes: “Ginseng and its constituents are known to have the beneficial effects on central nervous system (CNS) disorders including the cognitive performance, memory, and neurodegenerative diseases… Many studies have identified the neuroprotective properties of ginseng and ginsenosides… **Ginsenosides and other active constituents from ginseng are known to show neuroprotective properties and worked as cognitive performance and memory enhancer**.” It also discusses effects on neurotransmitter systems in the CNS, including modulation of dopamine and other monoamines.

“This systematic review aims to evaluate the available evidence from randomized clinical trials of the clinical efficacy and safety of ginseng… The main indications included glucose metabolism, physical performance, psychomotor function, sexual function, cardiac function, pulmonary disease, and cerebrovascular disease… We found strong evidence of a positive effect of ginseng on glucose metabolism, psychomotor function, and pulmonary disease, whereas evidence suggests that ginseng is not effective at enhancing physical performance… In conclusion, our review compiles the evidence on the use of ginseng, finding a strong positive potential for glucose metabolism, psychomotor function, and pulmonary disease, but not for physical performance.”

“Recent studies have advanced ginseng pharmacology and shown that ginseng has various pharmacological effects in the nervous system.” “Treatment with ginsenoside Rg3 has been found to stabilize excitable cells by blocking influxes of cations such as Ca2+ and Na+, or by enhancing Cl− influx.” “This review will detail the pharmacological applications of ginsenosides as neuroprotective drugs that target ion channels and ligand-gated ion channels.”

This meta-analysis of randomized controlled trials reports: "In the fixed-effects meta-analysis, ginseng supplements showed a statistically significant efficacy on fatigue reduction" but "there was no significant association between ginseng supplements and physical performance enhancement." The authors conclude that while ginseng may reduce fatigue, "there was insufficient clinical evidence to support the use of ginseng supplements on reducing fatigue and enhancing physical performance" due to few, small RCTs. The paper addresses fatigue (a CNS symptom) but does not describe ginseng as a classic CNS stimulant.

“Ginsenosides, which have been regarded as primary ingredients of ginseng, cannot elicit intracellular [Ca2+]i transients, since they lack specific cell surface receptors.” “To observe the pharmacological effects of ginsenosides, cells must be pre-stimulated by electrical currents, excitatory ligands, or other treatments or subjected to injuries like hypoxia or ischemia, in the case of organs… Second, ginsenosides must be applied at high micromolar concentrations (≈ 30–97 μM in EC50 or IC50) to elicit any physiological or pharmacological effects compared to other endogenous or exogenous ligands.” “Gintonin as a first messenger isolated from ginseng, binds only to cell surface LPA receptors with a high affinity and elicits cellular responses at less than nanomolar or nanomolar concentration ranges… Gintonin but not ginsenosides acts via a second messenger (Ca2+) and shows a consistent pattern in its actions.”

“Ginsenoside Rb1 is one of most important active ingredients in Panax ginseng and Panax notoginseng.” “In summary, current studies have demonstrated that ginsenoside Rb1 exerts neuroprotective roles through inhibiting oxidative stress, apoptosis and neuroinflammation and regulating the autophagy in neurodegenerative diseases, cerebral ischemia injury, depression and spinal cord injury.” “What’s more, increasing evidence has demonstrated that ginsenosides are involved in neuroprotective effects in the central nervous system diseases due to their antioxidant, anti-apoptotic, and anti-inflammatory features.”

“Administration of a standardized Panax ginseng extract for 8 weeks resulted in improvements in certain measures of psychomotor performance and perceived fatigue compared with placebo… The treatment did not significantly alter heart rate, blood pressure, or other physiological markers typically associated with CNS stimulants, indicating that its action may differ from classic stimulants such as caffeine.”

This randomized, double-blind, placebo-controlled trial assessed Panax ginseng in patients with multiple sclerosis–related fatigue. The authors report that Panax ginseng "did not show a statistically significant effect" on fatigue compared with placebo. They conclude that, in this study, ginseng "was not effective in reducing fatigue" in MS patients, suggesting that any central nervous system–related stimulant or activating effect is at least not robust in this population.

“Results of previous clinical trials demonstrate positive effects of Asian ginseng supplementation on stress-related symptoms… The authors concluded that Asian ginseng supplementation may improve aspects of mood and cognitive function under stress, although the size of the effect is modest and not all parameters showed significant changes. Further large, well-designed trials are required.”

“It was confirmed that Ginsenoside-Rg, the saponins from Ginseng root, which afforded panaxatriol on acid hydrolysis, does not have CNS-depressive activity.” “GF-DS-I appeared to have CNS-depressive, neuroleptic, analgesic, hypertensive, cholinergic, and histamine-like activities, while GF-DS-II had CNS-depressive, neuroleptic, analgesic, hypotensive, atropine-like and papaverine-like activities.” “These results, GF-DS-I appeared to have effects such as CNS-depression, tranquilization, analgesic, cholinergic, histamine-like, and hypertensive activities. GF-DS-II also appeared to have CNS-depression, tranquilization, analgesic, hypotensive, atropine-like and papaverine-like activities.”

“The effects of the saponin fraction of Panax ginseng and ginsenoside Rb1 on the central nervous system were studied in mice.” “The saponin fraction and ginsenoside Rb1 significantly prolonged the pentobarbital-induced sleeping time and reduced spontaneous motor activity.” “These results suggest that the saponin fraction of Panax ginseng and ginsenoside Rb1 have CNS-depressant effects.”

The U.S. Department of Defense–affiliated OPSS notes that “Some of the latest research has shown **improvements in brain health, specifically as related to performance on attention and memory-related tasks up to 6 hours after a single use of 200–400 mg of Panax ginseng**. No such effects have been reported with amounts greater than 400 mg.” It cautions that “Ginseng could **intensify the effects of stimulants such as caffeine** and could be dangerous when combined with certain medications,” and lists common side effects including insomnia and headache.

“Ginsenoside Rg1 is one of the main active components of Panax ginseng and has been reported to have central nervous system excitatory effects.” “In this study, ginsenoside Rg1-treated groups showed significantly improved learning and memory performance compared with the model group.” “The results suggest that ginsenoside Rg1 may exert a beneficial excitatory effect on the CNS related to cognitive function.”

“Asian ginseng is considered an adaptogen, meaning it helps the body cope with stress, and is often described as a ‘general tonic’ rather than a specific stimulant… Some people may experience nervousness and insomnia, particularly at higher doses, but human studies have not consistently shown strong stimulant effects on the central nervous system.”

“Asian ginseng is often called an ‘adaptogen,’ meaning it helps the body cope with stress. Asian ginseng may act as a stimulant in some people, or as a sedative in others.” “High doses may cause trouble sleeping, nervousness, and high blood pressure, suggesting a stimulating effect on the central nervous system in susceptible individuals.”

Healthline’s evidence-based summary notes: “Possible benefits of ginseng include **reducing inflammation, improving brain function**, and boosting the immune system.” It cites human trials in which Panax ginseng “**has been shown to improve mental performance, feelings of calmness, and mood in both healthy and cognitively impaired people,**” but also emphasizes that more high‑quality studies are needed and that not all trials show benefits.

Beyond sexual function, this systematic review notes that ginseng has been associated with central nervous system effects, including “**increased alertness and improved psychomotor performance**” in some trials, but also reports adverse events such as **insomnia and nervousness**. The authors point out that the overall quality of evidence is variable and that more rigorous studies are needed.

Widely cited pharmacology texts describe Panax ginseng as an ‘adaptogen’ that can modulate central nervous system activity, sometimes producing calming effects and sometimes mild increases in alertness, depending on dose and individual state. It is generally not classified alongside prototypical CNS stimulants (such as caffeine, amphetamines, or methylphenidate); instead, its effects are more subtle and variable, with many controlled trials showing either modest benefits on fatigue and cognition or no significant effect.